Literature DB >> 12209538

Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases.

T Glück, H-J Linde, J Schölmerich, U Müller-Ladner, C Fiehn, P Bohland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12209538     DOI： 10.1002/art.10374

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  12 in total

Review 1.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

Review 2.  [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors:  D Meyer-Olson; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

Review 3.  Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?

Authors:  Theodoros Kelesidis; Amandeep Salhotra; Jorge Fleisher; Daniel Z Uslan
Journal:  J Infect       Date:  2010-02-20       Impact factor: 6.072

Review 4.  Listeria-associated arthritis in a patient undergoing etanercept therapy: case report and review of the literature.

Authors:  Georg Schett; Petra Herak; Winfried Graninger; Josef S Smolen; Martin Aringer
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 5.  Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease.

Authors:  D C Sadowski; C N Bernstein; A Bitton; K Croitoru; R N Fedorak; A Griffiths
Journal:  Can J Gastroenterol       Date:  2009-03       Impact factor: 3.522

6.  Clinical course of patients with Behçet's uveitis following discontinuation of infliximab therapy.

Authors:  Tatsushi Kawaguchi; Yuko Kawazoe; Koju Kamoi; Masaru Miyanaga; Hiroshi Takase; Sunao Sugita; Manabu Mochizuki
Journal:  Jpn J Ophthalmol       Date:  2013-10-16       Impact factor: 2.447

7.  Listeriosis in patients receiving biologic therapies.

Authors:  M Bodro; D L Paterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-09       Impact factor: 3.267

8.  Listeria meningitis complicating infliximab treatment for Crohn's disease.

Authors:  Geoffrey Williams; Asad A Khan; Franzjosef Schweiger
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

Review 9.  Advances in sepsis therapy.

Authors:  Thomas Glück; Steven M Opal
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Existing medications among non-pregnancy-related listeriosis patients in England, 2007-2009.

Authors:  P Mook; J M Jenkins; S J O'Brien; I A Gillespie
Journal:  Epidemiol Infect       Date:  2012-03-12       Impact factor: 4.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.